MATV

Interested in Mativ Holdings, Inc.? Here are five stocks we like better. Mativ delivered record profitability in Q2 2026: Adjusted EBITDA rose nearly 12% to $75 million, with margin expanding to 14.1%, while free cash flow increased to $60 million on sales growth, pricing actions and cost management. Leverage and liquidity improved: Net debt fell $61 million sequentially to $908 million, leverage declined to 3.8 times, and refinancing extended the nearest maturity beyond three years. A Wisconsin tornado will weigh on Q3 results: Damage to a distribution center is expected to reduce third-quarter sales by $20 million to $25 million, although manufacturing remains operational and insurance is expected to substantially offset the financial impact. 3 High-Yield Dividend Stocks Trading at a Discount Mativ (NYSE:MATV) reported second-quarter 2026 results that included its highest quarterly adjusted EBITDA since the company’s formation, as pricing actions, cost management and footprint optimization supported profitability and cash generation. Net sales totaled $532 million, up more than 1% from a year earlier on a reported basis and nearly 2% organically. Adjusted EBITDA rose nearly 12% year over year to $75 million, while adjusted EBITDA margin expanded 130 basis points to 14.1%. Free cash flow increased to $60 million from $49 million in the prior-year quarter. → Sandisk Just Delivered a Blowout Quarter—Here's Why the Stock Is Falling President and CEO Shruti Singhal said the quarter reflected the company’s efforts over the past 18 months to transform its operating model, commercial organization and capital-allocation approach. She cited value-based pricing, cost programs and strategic footprint actions as contributors to the results. The company’s Filtration & Advanced Materials, or FAM, segment generated approximately $202 million in sales. Organic sales were largely flat, while reported sales declined 1% from the prior year. Mativ said lower filtration volume mix and the impact of its exited Wilson, North Carolina, facility were partly offset by favorable selling prices and foreign-currency translation. → 4 Oil and Gas ETF Plays as Prices Stay Sky-High FAM adjusted EBITDA increased 1% to $35 million, and the segment’s margin improved 50 basis points to 17.6%. The company said pricing gains and lower selling, general and administrative expenses outweighed higher manufacturing costs and lower volume mix. Sales in the Sustainable & Adhesive Solutions, or SAS, segment rose more than 2% year over year to $330 million, supported by higher selling prices and currency effects. Tapes and labels sales expanded nearly 10%, led by finished tape categories and tape backings, according to Singhal. Commercial print and packaging delivered flat to modest growth despite what management described as a declining underlying market. → No Hangover: Revisiting Microsoft One Week After Earnings SAS adjusted EBITDA increased more than 18% to a quarterly record of $50 million. Segment margin rose 210 basis points to 15.3%, as proactive pricing more than offset inflation and higher manufacturing, distribution and SG&A expenses. In healthcare, Mativ said operations at its Knoxville facility returned to normal in early in the second quarter after a temporary outage. The resulting volume recovery offset the continuing effect of separate customer destocking actions during the period. The company expects healthcare to remain a minor headwind to consolidated results during the second half of 2026. Chief Financial Officer Scott Minder said free cash flow benefited from lower restructuring expenses and capital-expenditure timing. Working capital represented 11.5% of sales, an improvement of 150 basis points from a year earlier, even as the company invested in inventory to support growth initiatives. Net debt was $908 million at the end of the quarter, down $61 million sequentially. Net leverage improved to 3.8 times, a 300-basis-point improvement from the first quarter and a 700-basis-point improvement over the past year, Minder said. Mativ refinanced much of its capital structure early in the second quarter, pushing its nearest debt maturity to more than three years away and staggering other anticipated maturities beyond 2029. The company said it expects leverage to reach the mid-to-high 3-times range by year-end and fall within its 2.5-times to 3.5-times target range by mid-2027. The company continues to expect full-year inflation of $40 million to $50 million, in line with its prior forecast. Management said the Middle East conflict contributed to higher crude oil and derivative prices during much of the second quarter, affecting costs for raw-material inputs. Mativ expects commodity costs to remain elevated through the rest of the year. Although pricing produced a favorable price-to-cost relationship during the second quarter, Minder said that benefit is expected to contract in the second half as higher raw-material costs are recognized. Mativ took pricing actions in late first quarter and early second quarter to address inflation in inputs, manufacturing and distribution. Singhal outlined Mativ’s growth strategy around three technology platforms: coating and saturation, extrusion manufacturing, and fiber solutions and specialized assembly. The company said the platforms are intended to guide capital deployment, connect technical capabilities across its portfolio and target higher-growth, higher-return markets. Mativ also highlighted a new aerospace and defense opportunity involving a customized lightweight specialty film for a global leader in space exploration. Singhal said the customer continues to test the product and that the program is ramping as planned. She did not disclose expected revenue because of confidentiality restrictions. Minder said the aerospace and defense film program is expected to support modest volume growth in the third quarter, excluding the impact of a tornado on the company’s paper and packaging operations. He said the company’s organic sales were about flat in the first quarter before growing nearly 2% in the second quarter, primarily driven by price, and that the company expects to add modest volume growth in the third quarter outside of the weather-related disruption. Mativ is also piloting artificial intelligence and data analytics tools to improve production scheduling and reduce process waste. The company said it plans to scale the efforts across its network if the pilot programs are validated. On July 27, a severe tornado damaged Mativ’s primary third-party paper and packaging distribution center in Menasha, Wisconsin. The company said all Mativ and third-party personnel were safe, and no production assets were affected beyond a short power outage. Manufacturing facilities remain fully operational. Mativ began limited customer shipments within 72 hours of the storm and has secured alternative warehouse space while rebuilding inventory and restoring distribution capacity. The company expects the event to reduce third-quarter sales by $20 million to $25 million, with modest recovery of those sales beginning in the fourth quarter. Management said it expects insurance coverage to substantially offset inventory losses and business-disruption costs, though the amounts and timing of recoveries have not yet been determined. Mativ said the impact should be manageable and largely contained to the third quarter. Before the tornado, the company expected to be modestly ahead of its record third-quarter 2025 adjusted EBITDA result of $67 million. Mativ did not provide an estimate for the storm’s third-quarter EBITDA impact, citing ongoing recovery work and assessment of the financial effects. Mativ is a global supplier of specialty fiber-based materials and engineered solutions, established in April 2021 through the spin-off of Ahlstrom-Munksjö’s global filtration and engineered materials business. Trading on the New York Stock Exchange under the ticker MATV, the company focuses on designing and manufacturing high-performance products for a broad range of end markets, including life sciences, energy storage, industrial filtration, and consumer products. Through its Advanced Solutions segment, Mativ produces innovative materials such as lithium-ion battery separators, specialty release liners, and pressure-sensitive adhesive tapes. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "Mativ Q2 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for August 2026.

Mativ Holdings (MATV) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.33 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +78.57%. A quarter ago, it was expected that this paper and reconstituted tobacco company would post earnings of $0.02 per share when it actually produced earnings of $0.06, delivering a surprise of +200%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Mativ Holdings, which belongs to the Zacks Chemical - Specialty industry, posted revenues of $531.8 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 4.58%. This compares to year-ago revenues of $525.4 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Mativ Holdings shares have lost about 24.3% since the beginning of the year versus the S&P 500's gain of 13%. While Mativ Holdings has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Mativ Holdings was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.34 on $528.1 million in revenues for the coming quarter and $0.85 on $2.01 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Specialty is currently in the top 43% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Another stock from the broader Zacks Basic Materials sector, Silvercorp (SVM), has yet to report results for the quarter ended June 2026. The results are expected to be released on August 10. This mineral miner is expected to post quarterly earnings of $0.21 per share in its upcoming report, which represents a year-over-year change of +110%. The consensus EPS estimate for the quarter has been revised 51.9% lower over the last 30 days to the current level. Silvercorp's revenues are expected to be $138.7 million, up 70.5% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Mativ Holdings, Inc. (MATV) : Free Stock Analysis Report Silvercorp Metals Inc. (SVM) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

This article first appeared on GuruFocus. Net Sales: $532 million, up nearly 2% year over year on an organic basis and up more than 1% as reported. Adjusted EBITDA: $75 million, a quarterly record, up nearly 12% versus prior year. Adjusted EBITDA Margin: 14.1%, up 130 basis points year over year. Free Cash Flow: $60 million, the strongest Q2 performance, up from $49 million in the prior year. FAM Segment Net Sales: Roughly $202 million, largely flat year over year on an organic basis and down 1% on a reported basis. FAM Segment Adjusted EBITDA: $35 million, up 1% year over year, with margins of 17.6%, up 50 basis points. SAS Segment Net Sales: $330 million, up more than 2% year over year. SAS Segment Adjusted EBITDA: $50 million, a quarterly record, up more than 18% year over year, with margins of 15.3%, up 210 basis points. Unallocated Expense: Roughly $11 million, up about $1 million versus prior year due to higher advisory expenses. Tax Rate: 47% in Q2, driven by geographical earnings mix and valuation allowances. Interest Expense: $19 million, up slightly versus prior year due to higher average borrowing rates. Net Debt: $908 million at quarter end, reduced by $61 million sequentially. Net Leverage: 3.8 times at end of Q2, improving by 300 basis points versus Q1 2026. Working Capital: Represented 11.5% of sales, improving by 150 basis points compared to prior year. Full-Year Inflation Impact: Expected to be between $40 million and $50 million for 2026. Q3 Sales Impact from Tornado: Estimated between $20 million and $25 million. Warning! GuruFocus has detected 5 Warning Signs with MATV. Is MATV fairly valued? Test your thesis with our free DCF calculator. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Record Q2 2026 performance with adjusted EBITDA of $75 million, up 12% year-over-year, and adjusted EBITDA margin of 14.1%, a 130 basis point improvement. Strong free cash flow of $60 million in Q2, the best second-quarter performance, driven by lower restructuring expenses and capital expenditure timing. Significant debt reduction with net leverage improving to 3.8x, down 300 basis points sequentially and 700 basis points year-over-year, ahead of expectations. SAS segment achieved record adjusted EBITDA and margins, with Tapes and Labels growing nearly 10% and commercial print outperforming market declines. New aerospace and defense win with a global space exploration leader, ramping up as planned and expected to drive growth into 2027 and beyond. Proactive pricing actions and cost-out initiatives are on track, with $15-20 million in cost savings expected for 2026, supporting margin expansion. Q3 2026 sales expected to be negatively impacted by $20-25 million due to tornado damage at a third-party distribution center in Wisconsin. Price-to-cost ratio expected to be less favorable in Q3 due to timing of price increases and higher raw material costs, partially offsetting Q2 gains. Healthcare category remains a minor headwind in the second half of 2026 due to ongoing customer destocking. Elevated commodity costs from the Middle East conflict are expected to persist, with full-year inflation impact of $40-50 million. Q2 tax rate was high at 47% due to geographical earnings mix and valuation allowances in certain jurisdictions. FAM segment volumes declined due to lower Filtration volumes and the exit of the Wilson, North Carolina facility, partially offset by pricing and currency. Q: Can you provide an update on the aerospace and defense win and what gives you confidence in the volume growth expected in Q3?A: Shruti Singhal (CEO) confirmed that the customized lightweight specialty film for a global space exploration leader is scaling as planned, though revenue details are confidential due to the high-value, high-demand nature of the product. Scott Minder (CFO) added that the pivot to volume growth in Q3, excluding the tornado impact, is driven by the ramp-up in the Films business related to this A&D win, which serves as the first major proof point of the company's growth strategy. Q: Can you help us understand the earnings bridge from Q2 to Q3, and how should we think about margin progression over the next couple of years?A: Scott Minder (CFO) explained that Q3 will see a transitory headwind from a tapering of the favorable price-to-cost ratio due to raw material cost timing, but this will be offset by structural tailwinds from new business wins and ongoing cost-out initiatives, resulting in a small net positive. Shruti Singhal (CEO) emphasized that the company is pivoting from cost-out to profitable growth, with a focus on deliberate choices in high-impact areas to drive long-term positive margin evolution. Q: Can you provide more color on the impact of the tornado in Wisconsin and the expected recovery?A: Shruti Singhal (CEO) expressed gratitude that all personnel are safe and detailed that the third-party distribution center for Paper and Packaging was extensively damaged, but all manufacturing operations remain fully operational. The company resumed limited customer shipments within 72 hours and expects the impact to be mostly contained to Q3 2026, with a sales impact of $20 million to $25 million and a modest recovery starting in Q4. Q: What were the key drivers of the record Q2 2026 financial results?A: Scott Minder (CFO) reported net sales of $532 million, up nearly 2% organically, and record adjusted EBITDA of $75 million, up 12% year-over-year, with margins expanding 130 basis points to 14.1%. The results were driven by a favorable price-to-cost ratio, proactive pricing actions, and cost management, partially offset by higher manufacturing and distribution expenses and lower volume mix. Q: How is the company progressing on its debt reduction and leverage targets?A: Scott Minder (CFO) highlighted that net debt totaled $908 million at quarter end, down $61 million sequentially, with net leverage improving to 3.8 times, down 300 basis points from Q1 2026 and 700 basis points year-over-year. The company expects to fully repay its revolver balance by year-end and reach its target leverage range of 2.5 to 3.5 times by mid-2027, ahead of previous expectations. Q: What is the expected impact of the Middle East conflict on raw material costs and pricing?A: Scott Minder (CFO) stated that the full-year 2026 inflation impact is expected to be between $40 million and $50 million, in line with prior estimates. The company proactively took pricing actions in late Q1 and early Q2 to offset cost increases, but expects the favorable price-to-cost performance to contract in the second half of the year due to timing of cost recognition. Q: Can you provide details on the performance of the SAS and FAM segments?A: Shruti Singhal (CEO) noted that the SAS segment delivered record-adjusted EBITDA and margins, with Tapes and Labels expanding by almost 10%. Scott Minder (CFO) added that SAS adjusted EBITDA was $50 million, up 18% year-over-year with margins of 15.3%, while FAM adjusted EBITDA was $35 million, up 1% with margins of 17.6%, driven by favorable price-to-cost ratios. Q: How is the company leveraging technology platforms and AI to drive growth and efficiencies?A: Shruti Singhal (CEO) outlined the company's three technology platformscoating and saturation, extrusion manufacturing, and fiber solutionswhich are designed to unlock integrated value and inform capital allocation. The company is also rolling out AI and data analytics pilots to optimize production scheduling and reduce process waste, with plans to scale these solutions across the network for sustainable cost savings. For the complete transcript of the earnings call, please refer to the full earnings call transcript.

ALPHARETTA, Ga., August 05, 2026--(BUSINESS WIRE)--Mativ Holdings, Inc. ("Mativ" or the "Company") (NYSE: MATV) reported financial results for the three-months ended June 30, 2026. Mativ Second Quarter 2026 Highlights1 Sales of $531.8 million increased 1.2% year over year, and 1.7% on an organic basis GAAP income of $3.6 million versus GAAP loss of $9.5 million in prior year period; GAAP EPS was $0.06 Adjusted income was $28.2 million; Adjusted EPS was $0.50 Adjusted EBITDA was $75.0 million, up 12% versus prior year period Adjusted EBITDA margin was 14.1%, up 130 basis points versus prior year period Cash from operating activities was $67.9 million, up 18% versus prior year period Free cash flow was $60.4 million, up 24% versus prior year period Management Commentary "We delivered our strongest financial quarter since becoming Mativ four years ago, combining modest organic sales growth with strong cost discipline to drive record adjusted EBITDA and margins," said Shruti Singhal, Mativ President and CEO. "Our disciplined execution generated exceptional free cash flow allowing us to materially improve our leverage. This strong performance is yet another proof point that our business continues to transform, further compounding on our record prior year results. We have implemented changes to our new business development process, operating cadence, and cost structure which are advancing our momentum as we navigate through 2026. We continue to identify and execute on new initiatives that will further accelerate progress toward our long-term objectives for sustainable, profitable growth, increased shareholder value, and an attractive leverage profile." Mativ Second Quarter 2026 Financial Results Filtration & Advanced Materials (FAM) segment sales, comprised primarily of filtration media and components, advanced films, coating and converting solutions, and extruded mesh products, were $201.7 million, down 0.1% on an organic basis, and 1.3% on a reported basis versus the prior year period, reflecting lower volume/mix in our Filtration & Netting business, including the impact from an exited facility, partially offset by higher selling prices and favorable currency. Adjusted EBITDA (see non-GAAP reconciliations) and margin increased 1.4% and 50 basis points, respectively, versus prior year as proactive pricing actions and lower SG&A expenses offset higher manufacturing costs and lower volume/mix. Sustainable & Adhesive Solutions (SAS) segment sales, comprised primarily of tapes, labels, liners, specialty paper, packaging and healthcare solutions, of $330.1 million were up 2.8% versus the prior year period. Higher selling prices and favorable currency were partially offset by lower volume/mix as strong growth in our Tapes, Labels & Liners business was offset by lower volume/mix across other categories. Adjusted EBITDA (see non-GAAP reconciliations) and margin increased 18.8% and 210 basis points, respectively, compared to the prior year period, as proactive pricing actions offset general cost increases including higher manufacturing and distribution costs and SG&A expenses. GAAP operating expenses decreased $1.9 million year-over-year, primarily due to $1.9 million in organizational realignment costs in the prior year period. Adjusted unallocated expenses (EBITDA) (see non-GAAP reconciliations) increased $0.7 million versus prior year primarily due to higher advisory expenses. Interest expense was $19.3 million versus $18.6 million in the prior year period, mainly due to higher average rates on the floating portion of our outstanding debt in 2026. Other expense, net was $0.5 million and compared to other income of $1.5 million in the prior year period. The decrease was primarily attributed to gains on asset disposals in 2025. Tax rate was 47% for the three months ended June 30, 2026, primarily driven by our geographical earnings mix and our inability to benefit from losses in certain jurisdictions that have a full valuation allowance. Non-GAAP Adjustments reflect items included in GAAP gross profit, income, and EPS, but excluded from adjusted results (see non-GAAP reconciliation tables for additional details). The most significant adjustments to the second quarter 2026 results were: $0.25 per share of purchase accounting expenses (purchase accounting expenses reflect primarily ongoing non-cash intangible asset amortizations associated with mergers and acquisitions) $0.16 per share of loss on debt extinguishment Cash Flow & Debt Year-to-date 2026 cash provided by operating activities was $68.9 million. Capital spending totaled $15.9 million. Working capital was a $2.6 million use of cash due to the impact of an increase in accounts receivable and inventories offset by an increase in accounts payable and accrued income taxes. This disciplined investment in working capital aligns with our strategic growth initiatives and positions us to serve customers in high-growth, high-return end markets. Total debt was $974.5 million as of June 30, 2026 and Cash and cash equivalents was $66.3 million resulting in net debt of $908.2 million. Total liquidity was approximately $345.5 million, consisting of $66.3 million of Cash and cash equivalents and $279.2 million of revolver availability. The Company's debt is expected to mature on a staggered basis through 2033. Dividends On August 5, 2026, the Company announced its next quarterly cash dividend of $0.10 per share payable on September 25, 2026 to stockholders of record as of August 28, 2026. Conference Call Mativ will hold a conference call to review second quarter 2026 results with investors and analysts at 8:30 a.m. Eastern time on Thursday, August 6, 2026. The earnings conference call will be simultaneously broadcast over the Internet at http://ir.mativ.com. To listen to the call, please go to the Company’s website at least 15 minutes prior to the call to register and to download and install any necessary audio software. For those unable to listen to the live broadcast, a replay will be available on the Company’s website shortly after the call. About Mativ Mativ Holdings, Inc. is a global leader in specialty materials, solving our customers’ most complex challenges by engineering bold, innovative solutions that connect, protect and purify our world. Headquartered in Alpharetta, Georgia, we manufacture on three continents and generate sales in over 100 countries through our family of business-to-business and consumer product brands. The company’s two operating segments, Filtration & Advanced Materials and Sustainable & Adhesive Solutions, target premium applications across diversified and growing categories. Our broad portfolio of technologies combines polymers, fibers and resins to optimize the performance of our customers’ products across multiple stages of the value chain. Our leading positions are a testament to our best-in-class global manufacturing, supply chain and materials science capabilities. We drive innovation and enhance performance, finding potential in the impossible. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") that are subject to the safe harbor created by the Act and other legal protections. Forward-looking statements include, without limitation, those regarding the Company’s business plans, strategies and outlook, the adequacy of our sources of liquidity and capital, our expectations regarding dividends and share repurchases, the amount of capital spending and/or common stock repurchases, future cash flows, purchase accounting impacts, and other statements generally identified by words such as "believe," "expect," "intend," "guidance," "plan," "forecast," "potential," "anticipate," "confident," "project," "appear," "future," "should," "likely," "could," "may," "will," "typically" and similar words. These forward-looking statements are prospective in nature and not based on historical facts, but rather on current expectations and on numerous assumptions regarding the business strategies and the environment in which the Company’s business shall operate in the future and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by those statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that may cause actual results to differ materially from our expectations as of the date of this release. These risks include, among other things, the following factors: Risks associated with the implementation of our strategic growth initiatives, including diversification, and the Company's understanding of, and entry into, new industries and technologies; Risks associated with acquisitions, dispositions, strategic transactions and global asset realignment initiatives of Mativ; Risks related to the impairment of goodwill; Adverse changes in our end-market sectors impacting key customers; Changes in the source and intensity of competition in our commercial end-markets; Adverse changes in sales or production volumes, pricing and/or manufacturing costs; Seasonal or cyclical market and industry fluctuations which may result in reduced net sales and operating profits during certain periods; Risks associated with our technological advantages in our intellectual property and the likelihood that our current technological advantages are unable to continue indefinitely; Supply chain disruptions, including the failure of one or more material suppliers, including energy, resin, fiber, and chemical suppliers, to supply materials as needed to maintain our product plans and cost structure; Increases in operating costs due to inflation and continuing increases in the inflation rate or otherwise, such as labor expense, compensation and benefits costs; Our ability to attract and retain key personnel, labor shortages, labor strikes, stoppages or other disruptions; Changes in general economic, financial and credit conditions in the U.S., Europe, China and elsewhere, including the impact thereof on currency exchange rates (including any weakening of the Euro) and on interest rates; A failure in our risk management and/or currency or interest rate swaps and hedging programs, including the failures of any insurance company or counterparty; Changes in the manner in which we finance our debt and future capital needs, including potential acquisitions; Changes in tax rates, the adoption of new U.S. or international tax legislation or exposure to additional tax liabilities; Uncertainty as to the long-term value of the common stock of Mativ; Changes in employment, wage and hour laws and regulations in the U.S. and elsewhere, including unionization rules and regulations by the National Labor Relations Board, equal pay initiatives, additional anti-discrimination rules or tests and different interpretations of exemptions from overtime laws; The impact of tariffs, the imposition of any future additional tariffs and other trade barriers, the effects of retaliatory trade measures, and the impact of tariff uncertainty on macroeconomic conditions; Existing and future governmental regulation and the enforcement thereof that may materially restrict or adversely affect how we conduct business and our financial results; Weather conditions, including potential impacts, if any, from climate change, known and unknown, and natural disasters or unusual weather events; Risks associated with international conflicts and disputes, such as the ongoing conflict between Russia and Ukraine, and conflicts in the Middle East, and their corresponding impact on global macroeconomic conditions (including volatility in oil prices), as well as adverse impacts on our ability to supply products into affected regions, due to the corresponding effects on demand, the application of international sanctions, or practical consequences on transportation, banking transactions, and other commercial activities in troubled regions; Compliance with the FCPA and other anti-corruption laws or trade control laws, as well as other laws governing our operations; Risks associated with pandemics and other public health emergencies; The number, type, outcomes (by judgment or settlement) and costs of legal, tax, regulatory or administrative proceedings, litigation and/or amnesty programs; Increased scrutiny from stakeholders related to environmental, social and governance ("ESG") matters, as well as our ability to achieve our broader ESG goals and objectives; Costs and timing of implementation of any upgrades or changes to our information technology systems; Failure by us to comply with any privacy or data security laws or to protect against theft of customer, employee and corporate sensitive information; Information technology system failures, data security breaches, network disruptions, and cybersecurity events; and Other factors described elsewhere in this document and from time to time in documents that we file with the SEC. All forward-looking statements made in this document are qualified by these cautionary statements. Forward-looking statements herein are made only as of the date of this document, and Mativ undertakes no obligation, other than as may be required by law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise. For a more detailed discussion of these factors, also see the information under the captions "Risk Factors" and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" in Mativ's most recent annual report on Form 10-K for the year ended December 31, 2025 and any material updates to these factors contained in any of Mativ’s future filings with the SEC. The discussion of these risks is specifically incorporated by reference into this release. The financial results reported in this release are unaudited. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such and should only be viewed as historical data. The financial results reported in this release are unaudited. Non-GAAP Financial Measures Certain financial measures and comments contained in this press release exclude restructuring and impairment expenses, certain purchase accounting adjustments related to prior acquisitions, organizational realignment costs, divestiture costs, interest expense, stock-based compensation expense, the effect of income tax provisions and other tax impacts, capital spending, capitalized software costs, cloud-based software costs and depreciation and amortization. This press release also provides certain information regarding the Company's financial results excluding currency impacts. This information estimates the impact of changes in foreign currency rates on the translation of the Company's current financial results as compared to the applicable comparable period and is derived by translating the current local currency results into U.S. Dollars based upon the foreign currency exchange rates for the applicable comparable period. Financial measures which exclude or include these items have not been determined in accordance with accounting principles generally accepted in the United States (GAAP) and are therefore "non-GAAP" financial measures. Reconciliations of these non-GAAP financial measures to the most closely analogous measure determined in accordance with GAAP are included in the financial schedules attached to this release. The Company believes that the presentation of non-GAAP financial measures in addition to the related GAAP measures provides investors with greater transparency on the information used by the Company’s management in its financial and operational decision-making. Management also believes that the non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company’s financial and operational performance in the same way that management evaluates the Company's financial performance. Management believes that providing this information enables investors to better understand the Company’s operating performance and financial condition. These non-GAAP financial measures are not calculated or presented in accordance with, and are not intended to be considered in isolation or as alternatives or substitutes for, or superior to, financial measures prepared and presented in accordance with GAAP, and should be read only in conjunction with the Company's financial measures prepared and presented in accordance with GAAP. The non-GAAP financial measures used in this release may be different from the measures used by other companies. View source version on businesswire.com: https://www.businesswire.com/news/home/20260805418535/en/ Contacts Chris Kuepper, IRCDirector, Investor Relations+1-770-569-4229Website: http://www.mativ.com

Metallus (MTUS) came out with quarterly earnings of $0.26 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.2 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this maker of steel large bars and seamless mechanical tubing would post earnings of $0.13 per share when it actually produced earnings of $0.18, delivering a surprise of +38.46%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Metallus, which belongs to the Zacks Steel - Speciality industry, posted revenues of $341 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 3.01%. This compares to year-ago revenues of $304.6 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Metallus shares have added about 17.3% since the beginning of the year versus the S&P 500's gain of 9.4%. While Metallus has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Metallus was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.30 on $336.15 million in revenues for the coming quarter and $0.84 on $1.27 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Steel - Speciality is currently in the top 4% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Mativ Holdings (MATV), another stock in the broader Zacks Basic Materials sector, has yet to report results for the quarter ended June 2026. The results are expected to be released on August 5. This paper and reconstituted tobacco company is expected to post quarterly earnings of $0.28 per share in its upcoming report, which represents a year-over-year change of -15.2%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Mativ Holdings' revenues are expected to be $508.5 million, down 3.2% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Metallus Inc. (MTUS) : Free Stock Analysis Report Mativ Holdings, Inc. (MATV) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

Ecolab (ECL) came out with quarterly earnings of $2.09 per share, beating the Zacks Consensus Estimate of $2.08 per share. This compares to earnings of $1.89 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +0.48%. A quarter ago, it was expected that this cleaning, food-safety and pest-control services company would post earnings of $1.7 per share when it actually produced earnings of $1.7, delivering no surprise. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Ecolab, which belongs to the Zacks Chemical - Specialty industry, posted revenues of $4.42 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 0.40%. This compares to year-ago revenues of $4.03 billion. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Ecolab shares have added about 3.4% since the beginning of the year versus the S&P 500's gain of 8.3%. While Ecolab has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Ecolab was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.15 on $4.7 billion in revenues for the coming quarter and $8.18 on $17.88 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Specialty is currently in the top 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Another stock from the same industry, Mativ Holdings (MATV), has yet to report results for the quarter ended June 2026. The results are expected to be released on August 5. This paper and reconstituted tobacco company is expected to post quarterly earnings of $0.28 per share in its upcoming report, which represents a year-over-year change of -15.2%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Mativ Holdings' revenues are expected to be $508.5 million, down 3.2% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ecolab Inc. (ECL) : Free Stock Analysis Report Mativ Holdings, Inc. (MATV) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

Interested in Mativ Holdings, Inc.? Here are five stocks we like better. Q1 profitability improved sharply, with adjusted EBITDA rising 28% year over year to $47.5 million and margin expanding to 9.9%. Management credited pricing actions, cost controls and operational changes for the stronger margin and cash flow performance. Healthcare-related weakness weighed on volumes, especially due to customer destocking and a temporary Knoxville facility outage, though that plant is now fully operational. Mativ expects conditions to improve in the back half of the year, while seeing strength in areas like filtration, paint protection, industrial films and specialty aerospace films. Debt reduction remains a top priority after Mativ refinanced most of its debt in April, simplifying the capital structure and pushing out maturities until late 2029. The company also expects continued pricing actions to offset higher input costs, which it now estimates at $40 million to $50 million for 2026. 3 High-Yield Dividend Stocks Trading at a Discount Mativ (NYSE:MATV) reported higher first-quarter profitability and improved cash flow despite mixed demand across its portfolio, with management pointing to pricing actions, cost controls and operational changes as key drivers of margin expansion. On the company’s first-quarter 2026 earnings call, President and Chief Executive Officer Shruti Singhal said the quarter marked Mativ’s strongest consolidated first-quarter margin and cash flow performance since its mid-2022 merger. She said the results reflected a yearlong transformation focused on cost discipline, portfolio review, cash generation and debt reduction. → Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum “We are no longer reacting to the market,” Singhal said. “We are actively shaping our outcomes and focusing aggressively on things we can control.” Chief Financial Officer Scott Minder said net sales were $480 million, nearly flat year over year on an organic basis and down about 1% as reported. Favorable selling prices and currency were offset by lower volume mix. Adjusted EBITDA was $47.5 million, up 28% from the prior year, while adjusted EBITDA margin expanded 220 basis points to 9.9%. → 3 Ways to Target the Resources Powering AI and Data Centers Minder said Mativ’s Filtration & Advanced Materials, or FAM, segment posted net sales of $188 million, up more than 2% organically and modestly higher on a reported basis. The increase was driven by favorable currency and slightly higher selling prices, partially offset by lower volume mix. FAM adjusted EBITDA rose 41% year over year to $27 million, while margins improved 430 basis points to 14.6%. Minder attributed the gains to favorable price-to-input cost performance, lower manufacturing costs, favorable currency and reduced SG&A expenses. → Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players The Sustainable & Adhesive Solutions, or SAS, segment reported net sales of $291 million, down 2% year over year. Lower volume mix, primarily tied to healthcare, was partially offset by favorable currency and selling prices. SAS adjusted EBITDA increased about 16% to roughly $31 million, with margins up 160 basis points to 10.5%. Minder also noted a reporting change beginning in the quarter. Certain centralized expenses, including IT infrastructure, finance and accounting shared services, and regional human resources, are now allocated directly to the company’s segments. He said the change lowers reported adjusted EBITDA margins for both segments by about 100 basis points but does not affect consolidated adjusted EBITDA or margin. Singhal said the company experienced “a few discrete pockets of volume weakness,” most notably in healthcare. She cited customer destocking in the first quarter of 2026, compared with inventory building in the prior year to support product launches, as well as supply chain inefficiencies tied to a temporary outage at Mativ’s Knoxville, Tennessee, facility. During the question-and-answer session, Singhal said the Knoxville outage has been fully resolved and the plant is fully operational. She said Mativ does not have an exact timeline for normalization in healthcare because it depends on customer end-user demand, but she described the issue as near term and said the company expects improving trends in the back half of the year. Beyond healthcare, Singhal said demand remains soft in release liner and labels. However, she pointed to strength in European filtration, including aftermarket transportation, water and industrial applications, as well as gains in paint protection and industrial films. In SAS, she said Mativ saw growth across finished tape categories and commercial print. Singhal also said the company recently secured a “sizable new commitment” for specialty films from a new aerospace customer. In response to an analyst question, she declined to disclose financial terms or precise timing because of customer confidentiality, but said the commercial relationship is expected to begin in the second quarter, with shipments starting later in the quarter and ramping slowly. Free cash flow was a use of $7 million in the first quarter, improving by more than $22 million from the prior year. Minder said the improvement reflected more than $16 million of operating cash flow improvement, lower restructuring expenses and capital expenditure timing. He noted that the first quarter is historically Mativ’s most demanding period for cash flow because of seasonal working capital buildup and prior-year incentive compensation payouts. At quarter end, net debt was approximately $954 million, and liquidity was roughly $499 million. Net leverage, as defined in the company’s credit agreement, was 4.1 times, slightly lower than the 2025 year-end level. Minder said debt reduction remains Mativ’s primary capital allocation priority and that the company continues to expect progress toward its leverage goal of 2.5 times to 3.5 times during 2026. In April, Mativ refinanced the majority of its debt tranches. Minder said the transaction simplified the capital structure, reduced the number of bank group participants from 15 to eight, right-sized the revolving credit facility to $305 million and eliminated the delayed draw term loan. The revised revolver and new $90 million Term Loan A mature in 2031, while a new $500 million Term Loan B matures in 2033. Minder said Mativ now has no debt maturities until late 2029 and expects annual interest expense of about $76 million, slightly above the $74 million estimate under the prior structure. Management said the ongoing Middle East conflict had limited direct impact on Mativ in the first quarter, largely because of localized supply chains. However, both Singhal and Minder said the conflict has increased input cost volatility, particularly for oil-derived materials such as polymers, resins and certain chemical feedstocks. Minder said the company initially expected 2026 raw material inflation of $20 million to $25 million and took pricing action in January to offset it. Based on current forecasts, Mativ now expects full-year input cost inflation of $40 million to $50 million. Minder said the company took additional pricing actions across all product categories late in the first quarter and expects those actions to fully recover the additional costs in 2026. Asked whether Mativ would continue raising prices if input costs rise further, Minder said the company would “follow the same playbook” and take further pricing actions to preserve margins. He said management expects inflation to be “pretty sticky” in 2026 because of infrastructure damage, higher logistics and insurance costs, and a lingering risk premium in oil-related markets. Looking ahead, Minder said market volatility and geopolitical events have reduced forward visibility. Mativ expects second-quarter adjusted EBITDA to decline by a mid-single-digit percentage compared with a strong prior-year period, primarily because of lower volumes tied to near-term demand weakness in healthcare. He said growth in FAM’s films and filtration businesses, favorable price-to-input cost performance and SG&A savings should provide partial offsets. Singhal said Mativ’s newly formalized strategic blueprint will guide the company’s next phase, with a focus on becoming the preferred global partner for customers delivering performance-critical material solutions. She said the company will concentrate resources on high-growth, high-return markets, pursue cross-selling opportunities and apply existing capabilities to adjacent markets. “We have the right talent, the right portfolio, and we refined our strategy blueprint to lead Mativ into its next phase of profitable growth,” Singhal said. Mativ is a global supplier of specialty fiber-based materials and engineered solutions, established in April 2021 through the spin-off of Ahlstrom-Munksjö’s global filtration and engineered materials business. Trading on the New York Stock Exchange under the ticker MATV, the company focuses on designing and manufacturing high-performance products for a broad range of end markets, including life sciences, energy storage, industrial filtration, and consumer products. Through its Advanced Solutions segment, Mativ produces innovative materials such as lithium-ion battery separators, specialty release liners, and pressure-sensitive adhesive tapes. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "Mativ Q1 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for May 2026.

Image source: The Motley Fool. Thursday, May 7, 2026 at 8:30 a.m. ET Chief Executive Officer — Shruti Singhal Chief Financial Officer — Scott Minder Operator Shruti Singhal: Thanks, Chris. Good morning, everyone, and thank you for joining our call. We appreciate your time and your continued interest in Mativ. I am delighted to share our financial results, provide operational updates and formally introduce the next phase of our strategic evolution. Before we discuss the Q1 performance, I would like to pause and reflect on a meaningful milestone. This marks my first full year as Mativ's CEO. Looking back at the last 12 months, I am deeply inspired by our global workforce's resilience, adaptability and unwavering commitment. Having navigated complex macroeconomic and more recently, geopolitical landscapes, the transformation we initiated a year ago is bearing fruit, placing us on a firmer foundation today. The cultural shift driven across the organization fundamentally altered our operational DNA. We are no longer reacting to the market. We are actively shaping our outcomes and focusing aggressively on things we can control. This pivot is evident enterprise-wide, widened margin, optimized SG&A expenses, transform cash flow and a unified team culture. Our actions remain swift deliberate and impactful. Over the trailing 12 months, we transformed Mativ into an agile and more capable organization by holding firm to the following foundational priorities. First and foremost, we are an integral part of our customers' value proposition and the engine that powers their innovation efforts. Our highly engineered solutions are critical to our customers' success and our collaborative and co-creative relationships have never been more stronger. Usually, our solution is only a small portion of their final product's cost, but it is key to enabling its value and performance. Second, our rigorous cost-cutting initiatives yielded nearly $20 million in realized savings across SG&A, operations and procurement in 2025. And our 2026 cost savings target of $15 million to $20 million is proceeding on schedule. The aggressive steps we are taking, simplifying operational workflows, removing bottlenecks and cutting inefficiencies, directly impact our bottom line. Third, we made significant progress in our delevering efforts, enabled by improved profit margins and cash flow generation. In early April, we successfully refinanced the majority of our debt tranches. Scott will share more details but this transaction solidified and simplified our capital structure, derisked our balance sheet and enhanced Mativ's financial flexibility. Lastly, a year ago, we announced a strategic portfolio review of our assets and business lines to better balance the contribution of our product categories across a variety of financial and market dimensions. As a result, we took decisive actions on facilities, products and assets. We optimized our operational footprint by closing an underperforming plant in Wilson, North Carolina. We successfully streamlined our SKUs to reduce complexity and improve supply chain efficiency. Furthermore, we optimized our R&D initiatives and purposefully reallocated resources towards the highest return projects that directly support our commercial pipeline. By rigorously evaluating our business lines and taking these necessary actions, we have strengthened our foundation and position ourselves for the next phase of strategic transformation. We will now shift our focus to accelerating growth, better aligning our broad capabilities with the strongest markets and opportunities to drive sustainable long-term value. As part of our strategic planning process, we will continue to evaluate opportunities to create value by optimizing assets, costs and capital allocation. Transitioning to our Q1 performance. This was a solid opening to the year by maintaining a relentless focus on commercial excellence, pricing implementation, financial and operational discipline, we achieved year-over-year profitability growth despite the surrounding economic headwinds. Scott will walk you through the financials in detail, but I'll point out that the true highlights of this quarter lie in our profit margin expansion and cash flow performance, marking our strongest consolidated Q1 margin and cash flow performance since our mid-2022 merger. Both segments generated significant adjusted EBITDA and margin increases. Our strategic pricing initiatives and stringent cost controls are working in tandem to create value. Looking past the P&L, our free cash flow narrative remains a point of immense pride, building on phenomenal cash flow generation from last year. Historically, Q1 is our most demanding quarter for cash flow due to seasonal working capital buildups. Nonetheless, we achieved significant year-over-year improvement, which is a substantial step change from the heavy use of cash in the prior year. Our tactics have become highly cash flow centric, providing us with liquidity to navigate uncertainties while paying down debt. This also lays a solid foundation for another year of strong cash flow performance. While incredibly proud of our adjusted EBITDA margin and cash flow performance, we operate in a volatile macro environment, where the overall demand picture remains mixed across our portfolio. In Q1, we experienced a few discrete pockets of volume weakness across our diversified business portfolio. Most notably, within our health care vertical. First, customer destocking actions in Q1 2026 compared to customer inventory building in the prior year to support their product plans. Second, we experienced supply chain inefficiencies related to a temporary outage late in the quarter at our Knoxville, Tennessee facility. Beyond health care, demand remains soft in our release liner and labels businesses. Despite these headwinds, Mativ's strength lies in diversification. Our global reach and varied product portfolio allows us to accelerate on pockets of growth to offset weakness. As evidenced, in our FAM segment, our European filtration business demonstrated solid momentum, particularly in aftermarket transportation, water and industrial applications. We also captured gains in paint protection and industrial films. In our SAS segment, we saw growth across all finished have categories and in commercial print. Lastly, I'm pleased to report that we recently earned a sizable new commitment for specialty films from a new aerospace customer. This is another proof point for our strategy of applying existing process capabilities and product knowledge to grow in adjacent markets. In addition, we are focused on extending our commercial pipeline by increasing wallet share via cross-sell opportunities with existing customers and leveraging our broad product portfolio in adjacent applications. I'll highlight that FAM sales pipeline has materially increased versus a year ago, an important tool to offset sluggish market demand going forward. Switching gears to the impacts related to the global macro landscape. We saw limited direct impact from the Middle East crisis in the first quarter, primarily due to our localized supply chains. Looking ahead, given the elevated oil and derivative prices, we expect input cost increases in resins, polymers and select chemicals. Our commercial and procurement teams work in lockstep, leveraging our pricing agility and remaining proactive on further pricing actions to maintain a favorable price versus cost ratio for 2026. We had already implemented pricing actions in January due to the expected raw material inflation forecasted for 2026. When the subsequent Middle East crisis amplified this forecast, we announced the second pricing action in March to cover those incremental input costs. Although the direct impact of the current Middle East crisis on Mativ are minimal and well within our control, we recognize that the broader indirect impact on market demand and overall commercial activity remain uncertain. Our pricing agility allows us to capture the benefits sooner and more evenly, preserving margins during times of stress. Our strategic pricing efforts ensure that we realize higher margins over time. Pivoting to the future, as introduced on our last earnings call, we have formalized a new strategic blueprint that will guide how Mativ grows its top line, operates and wins in the marketplace. We have defined a clear unified vision for Mativ to be the preferred global partner for customers, delivering performance-critical material solutions. At the heart of this strategy, is our core purpose. Our materials and solutions are the key components that enable and elevate our customers' innovations. Whether we are purifying air and liquids, protecting surfaces in harsh conditions, ensuring materials stick and release on demand or ensuring life-saving devices stay attached to your body, our solutions are the critical components that make this progress possible. We succeed by playing to our strengths. We go beyond just supplying products by transforming materials into performance. With uncompromising quality, global reach and deep customer collaboration, we help solve their most complex challenges. In today's dynamic environment, we must relentlessly pursue ease, speed and reliability. We are actively focusing our sustainability and innovation efforts, leveraging our technical capabilities to accelerate progress across our key growth areas. We are continuing to optimize operations to run a faster, more efficient business. We want to make it effortless for customers to work with us, ensuring we exceed expectations every time they engage with us. We are making deliberate strategic choices to invest where we can win and grow. This means aggressively advancing our go-to-market strategy, unlocking the full integrated value of our diverse portfolio and concentrating our resources on high-growth, high-return markets. As we continue to refine our go-to-market strategies, over the coming months, we will keep you informed on our progress and impact. We have the right talent, the right portfolio, and we refine our strategy blueprint to lead Mativ into its next phase of profitable growth and on a clear path to long-term value creation. With that, I'll turn the call over to Scott to provide a more detailed overview of our financial performance. Scott Minder: Thanks, Shruti, and good morning. With solid first quarter results, Mativ laid a strong foundation to achieve our 2026 strategic and financial objectives. Starting with our financials. Matt net sales were $480 million nearly flat year-over-year on an organic basis and down about 1% as reported. Favorable selling prices and currency were offset by lower volume/mix. Q1 adjusted EBITDA was $47.5 million, up 28% versus prior year, a favorable price-to-input cost ratio lower manufacturing expenses and favorable currency were partially offset by unfavorable volume mix. Our adjusted EBITDA margin was 9.9% and which was up 220 basis points versus prior year. This represents our strongest Q1 margin performance since the mid-2022 merger. Looking at results by segment. FAM net sales of $188 million increased by more than 2% on an organic basis and were up modestly on a reported basis, both versus prior year. This growth was driven by favorable currency and slightly higher selling prices. These benefits were partially offset by lower volume/mix. FAM adjusted EBITDA of $27 million increased by 41% year-over-year, while margins of 14.6% improved by 430 basis points over the same period. These gains were led by a favorable price-to-input cost ratio, lower manufacturing costs, favorable currency and lower SG&A expenses. Marginally lower volume mix partially offset these benefits. SAS net sales of $291 million were down 2% year-over-year. Lower volume mix was partially offset by favorable currency and selling prices. As Shruti mentioned, this was driven mainly by lower-than-expected health care volumes. SAS adjusted EBITDA of roughly $31 million increased by approximately 16% year-over-year with margins of 10.5%, improving by 160 basis points. Earnings benefited from a favorable price-to-input cost ratio and reduced SG&A expenses. This was partially offset by lower volume mix. Before I cover corporate I want to highlight a reporting change that we implemented this quarter. As a legacy of our 2022 merger, a portion of our overhead costs remained unallocated at the corporate level. To better reflect the underlying costs of our business, we'll now allocate certain centralized expenses, specifically IT infrastructure, finance and accounting shared services and regional HR directly to our segments. As a result, adjusted EBITDA margins for both segments are approximately 100 basis points lower than originally reported. This change represents an internal expense reallocation. Consolidated adjusted EBITDA and margin remained unchanged. To assist with modeling and to ensure accurate year-over-year comparisons, we recently published an 8-K providing restated quarterly figures for 2025. Now looking at corporate items, unallocated expense of roughly $11 million increased by nearly $2 million versus prior year due to higher advisory expenses. Other income of roughly $2 million compared to an expense of $2 million in the prior year. This improvement was due to foreign currency gains. Our Q1 tax rate was negative, driven by our geographical earnings mix and our inability to benefit from losses in certain jurisdictions that have a full valuation allowance. Q1 interest expense of roughly $18 million decreased slightly versus prior year, primarily due to lower debt balances. Q1 2026 free cash flow was a use of $7 million, improving by more than $22 million versus prior year. This represents our best Q1 performance since the merger in mid-2022. It was driven by a year-over-year operating cash flow improvement of more than $16 million due to lower restructuring expenses and capital expenditure timing. At quarter end, net debt was approximately $954 million, representing a slight seasonal uptick as we invest in inventory ahead of our increasing Q2 and Q3 production schedules. Our liquidity was roughly $499 million on a reported basis, while our net leverage as defined in our credit agreement was 4.1x. This marks a slight decrease versus 2025 year-end level. We continue to expect material progress towards our leverage goal of 2.5 to 3.5x as we move through 2026. Debt reduction remains our primary capital allocation priority. After a comprehensive review of our capital structure, we refinanced our existing credit facilities in April, ahead of an early May [ go-current ] date for a significant portion of these facilities. As a result, we simplified our capital structure reducing the number of outstanding debt tranches as well as the number of bank group participants from 15 to 8. We rightsized our revolving credit facility to $305 million, reducing unused borrowing fees as a result, and we eliminated our delayed draw term loan. The revised cash flow revolver and new $90 million term loan A facilities mature in 2031 and the new $500 million term loan B matures in 2033. While the Middle East conflict added an element of volatility to our capital raising efforts, we chose to move quickly and derisk our upcoming maturities with new capital at market prevailing terms. We expect our annual interest expense to be approximately $76 million going forward, marginally above the $74 million we estimated for our previous capital structure. With our new facilities in place and no debt maturities until late 2029, we're focused on executing in the marketplace, generating strong free cash flow and addressing our prepayable debt tranches to further delever and strengthen our balance sheet. Next, I'd like to spend a few minutes providing some context on recent geopolitical events and how they've impacted our markets and our business. The current Middle East conflict has heightened volatility and increased our input costs. Oil prices have risen sharply since early March, and we're facing higher costs for many of our crude oil-based inputs, namely polymers, resins, and some chemical feedstocks. Coming into 2026, we estimated full year raw material inflation to be $20 million to $25 million across our basket of purchases with increases weighing more heavily on the second half of the year. We took pricing action in January to fully offset this inflation within 2026. Based on today's forecasted input costs, we now estimate total full year inflation impact to be $40 million to $50 million. As a result of this revised view, we took incremental pricing actions across all product categories in late Q1 to fully recover these additional costs. While these actions are challenging for our customers and our teams, they're clearly linked to underlying inflation. Similar to our efforts and results in 2025 and Q1 2026, we expect our pricing actions fully offset the $40 million to $50 million of forecasted input cost inflation in 2026. Our input cost inflation estimates are subject to material changes depending on geopolitical events and market expectations. We'll remain vigilant and nimble with our pricing, and we'll keep you updated over the coming months. Now I'll share our Q2 2026 outlook. Our first quarter results built a strong foundation for the year, highlighted by solid profitability, margin growth and improved cash flow performance. As we look ahead, the market volatility created by geopolitical events and its impact on our business reduces our forward visibility. As Shruti outlined earlier, we expect direct business impacts from the Middle East crisis to be manageable as we take steps to mitigate challenges quickly. This includes price increases to offset additional input cost inflation. We're closely monitoring for any potential indirect impact on broader market demand. Our new strategic growth blueprint is designed to counteract fluctuating market conditions by unlocking our portfolio's integrated value and by focusing our resources on high-growth, high-return opportunities and market adjacencies. Bottom line, we're taking actions on things within our control, and deploying mitigation strategies for those things beyond our control. As a result, we expect Q2 adjusted EBITDA to be down a mid-single-digit percentage compared to a strong prior year as a result of lower volumes, largely due to near-term demand weakness in our health care business. As Shruti discussed earlier, growth in FAM's films and filtration businesses a favorable price to input cost ratio and SG&A savings should provide partial offsets. A year ago, we successfully adapted to a new tariff-based macro environment, improved the resilience of our operations. Today, we're confident in our ability to manage through the input cost volatility and demand uncertainty created by geopolitical events. With that, I'll hand the call back to Shruti for his closing remarks. Shruti Singhal: Thank you, Scott. In closing, our first quarter results clearly demonstrate that the cultural and operational transformation we set in motion over the past year is working. We delivered our strongest Q1 consolidated margin and cash flow performance since our mid-2022 merger. This was comprised of significant margin improvements across both segments and a substantial step change in cash flow generation, setting us up for another year of strong free cash flow. While we are closely monitoring the broader macroeconomic environment and geopolitical headwinds, particularly the recent inflationary pressures on our input costs, we have proven our ability to be nimble, proactive and adapt to the world around us. Our commercial agility, value-based pricing strategies, and rigorous operational discipline give us the confidence that we can successfully navigate this volatility and continue to deliver consistent results in times of uncertainty. Looking ahead, our newly formalized strategic blueprint is actively guiding our growth trajectory. We are not waiting to see how the market evolves, we are leading it. Our commitment is to unlock the full integrated value of our diverse portfolio and to be the preferred global partner for customers, delivering performance-critical solutions. By concentrating our resources on high-growth, high-return markets and relentlessly focusing on quality, performance and reliability, we are charting a clear path towards profitable growth and sustain long-term value creation. With that, let's open the line for your questions. Operator? Operator: [Operator Instructions] Your question comes from the line of Daniel Harriman from Sidoti. Daniel Harriman: Congrats on the continued progress. I've got quite a few this morning to please bear with me, but I'll start out with two. First for Shruti, you mentioned customer destocking at supply chain inefficiencies within the health care vertical. And I was just hoping you might be able to provide a little bit more detail on this development and when we should expect conditions to normalize? And then Scott, as it pertains to price cost, you've done a really good job of offsetting costs with some pricing, and it sounds like you were able to get ahead of some expected inflation thus far in 2026 through these price increases. Do you think you'll be able to continue driving the favorable pricing should input costs continue to rise? And then conversely, should cost come down quicker than we expect, do you expect to reduce prices? Shruti Singhal: Thanks, Dan, for your question and your kind words. I appreciate it. Regarding our health care vertical. So we had 2 specific challenges. One was around customer destocking action. So it's created a bit of a tough comparison to prior year. So when customers were building inventory, we supported them in their product launch plans. So we're lapping that right now. Secondly, we had an issue with a temporary operational outage in our Knoxville, Tennessee plant, which is now fully resolved, and the plant is fully operational at this time. So on the point about normalization we don't have an exact time line on that based on customer, end user demand. But this is only a near-term issue for us. We do expect that at the back half, things would start to get better and we see an improving trend. But one thing to keep in mind, which I mentioned during my remarks as well, that the strength in our portfolio is the very diverse portfolio we have. So if one category goes down, we are offsetting these near-term headwinds with, for example, our European filtration business is strong. Our finished [ tapes ] business is strong. And what I mentioned about the new commitment and films and with the customers in aerospace, that's strong. So we have other things to offset this near-term demand weakness in our health care category. Scott? Scott Minder: Sure. Dan. First, thanks for the recognition. Pricing is not easy work for our teams. It requires a lot of analysis and back and forth with the customer. And it also really requires being proactive when costs are rising quickly to preserve margins. So -- but on to your question about what's next. First, I think it's important to appreciate that the ongoing conflict in the Middle East has created some significant longer-term disruption to oil and related markets for a couple of reasons. I mean there's been pretty significant infrastructure damage in the region. It has created elevated logistics and insurance costs, and I think those are going to be with us for a while. And even longer term, I think there's going to remain a lingering risk premium in the market for some time. So as a result of that, we expect input cost inflation to be pretty sticky in 2026, regardless of the timing for a resolution. So a quick reduction to a lower baseline price is not likely in our view. On the flip side, if the conflict does intensify and oil prices rise and settle at a higher level we're going to follow the same playbook. We're going to take further pricing actions to preserve our margins. So that's really the more tactical view. If we take a step back, I think pricing plays 2 important roles at Mativ, and Shruti talked a little bit about this. In the near term, it is critical for margin management, as I described. Over the longer term, I believe it's a critical part of our customer and shareholder value proposition. Over the last 12 months, this company has been on a mission to improve our margins. We've taken hard, but needed, actions to reduce our footprint and our SG&A costs, and we've improved our operations and supply chains to reduce complexity. We're really focused on preserving this foundation and make progress on our long-term objective around margins. And to get there, and more importantly, to stay there, it requires pricing actions to offset inflation. And then lastly, I think long term, as I mentioned, we strongly believe that margin management is a critical component of our value creation. For customers, it really does enable longer-term investments in innovation and capabilities. And for our shareholders, it improves the health and stability of our financial results. So I think this is really good work that we're doing, and we're going to continue down this path regardless of the situation presented to us externally. Daniel Harriman: That's really helpful, guys. Moving on, Shruti, we were excited to see or hear about the commitment of specialty films from a large aerospace customer. Can you quantify for us maybe the expected revenue impact that, that commitment is going to have and maybe the time line for when we should see results contributing to the overall business? And then, Scott, going back to you, cash flow generation -- free cash flow generation in the first quarter was up significantly year-over-year. But I'm just curious, given the seasonal working capital build as the year progresses, how should we think about that cash flow cadence for the balance of 2026. Shruti Singhal: Thanks, Dan, for the question there. I'll take the first one. I mean, we are super excited about this new specialty films commitment for the aerospace customer. Let me tell you, this is a great example where cross-functional teams within Mativ come together. We take our existing product-based, technology, innovate to customers' needs and their unmet need, and we grow in adjacent and really high-value markets. Now due to customer confidentiality, I can't really disclose the financial terms or be very precise on the timing for Mativ's revenue contribution. But what I can say is that we expect the commercial relationship to commence in Q2 and it's going to ramp up slowly with shipments starting later in the second quarter. But this is a great example of the strategic blueprint point that I was making earlier that it brings everything together. We created a strong foundation. Now we are innovating with customer needs and serving the market and expanding into high-value markets. So we are very excited about it, and I'm very proud of our team on what they've been able to accomplish with the customer. Scott Minder: Okay. Over to me. Question on cash flow. A little bit about our seasonal pattern here. I mean historically, Q1 is our most demanding cash flow period for a couple of reasons. We called out that we generally have seasonal working capital build ahead of higher Q2 and Q3 production levels. And second, we also have outflows in the first quarter related to the payout of the prior year's incentive compensation. So it was -- I think you noted, Dan, that in Q1, free cash flow was a use of $7 million. But that was a $22 million improvement year-over-year. Two components to that, largely due to improved earnings and then business realignment costs of $9 million in the prior year that didn't recur. So if we look ahead across 2026, we do expect a normal cash flow seasonality to the business. And by that, I mean, we expect to generate our strongest cash in Q2 and Q3 and close out the year on a positive note. As a reminder, though, I do want to point out back in February, we did say we plan to invest additional cash in 2026 for growth. So $10 million additional working capital and $5 million of additional CapEx. And I think you can think about that spending as being proportional across the remainder of the year. I think it is important to recognize that Mativ has intensified its focus on free cash flow over the last 12 months. Our teams, as we've talked, have worked really hard to improve profit margins, increase working capital efficiency. And we've really shown a lot of discipline around capital expenditures. So as a result, we did generate record free cash flow, as we've mentioned a couple of times now, of $94 million in 2025 amidst some pretty challenging market conditions for us. And as we said last quarter, we're on track to generate significant free cash flow again in 2026, and that's despite the market volatility that we're experiencing. So the bottom line here for me, the team is highly focused on delivering value through cash generation and capital allocation across all types of market environments. Daniel Harriman: Great, guys. I appreciate that. And then if I may, Shruti, just the last one. You mentioned moving on to the next phase of the comprehensive portfolio review that you've been undertaking for quite some time now. And to the extent that you can talk about it, I'm just curious if we should expect any divestitures of noncore assets as you complete the first phase and move on to the next. Shruti Singhal: Thanks again, Dan. So as I've mentioned before and over the last 12 months, we did a very rigorous portfolio analysis, the Board, the management team, across all our facilities, different product categories, various assets, and we wanted to make sure that we strategically balance each of those categories, what the contribution they make across lots of factors and characteristics went into it, such as the impact they have on the bottom line and what's our competitive position, how does it impact the margin profile and the overall focus around product diversity in our portfolio. So as I also mentioned, this resulted in, for example, a closure of our Wilson, North Carolina plant. The team did a really nice job on SKU rationalization. We've been -- a significant impact on that. That has an impact on our -- how we run our plants, the efficiencies, the working capital, all of the above. And then also on our R&D resources. We align our R&D resources and projects to the ones that have a high return on our investment and that are really needed by our customers. So really putting our customers first there. So those are some of the things we've made some very, very decisive actions. So we -- as we are doing this, we have really strengthened our foundation. We have demonstrated that over the last 4 quarters, and we position ourselves for the next step, which is our strategic transformation that I mentioned, our strategic blueprint, which is to guide Mativ's top line growth, how we continue on our operational and financial discipline and execution so that we keep winning in the marketplace like the example I gave on the specialty films in the aerospace. So of course, the Board and I and the management team, we will continue to evaluate our businesses for opportunities that come in to optimize our assets and facilities and cost and cash utilization that Scott was alluding to. But today, we believe at Mativ that we have a broad portfolio that is really well positioned to win in the market, and we can pursue the areas that we feel are the strongest for the long-term profitable growth of Mativ. So -- we -- that's why we're moving forward with our strategic blueprint and really focusing on operations as well as on the top line growth. Operator: We have reached the end of the Q&A session. I will now turn the call back to Shruti Singhal for closing remarks. Shruti Singhal: Thank you. Finally, a sincere thanks to all our Mativ employees. Your dedication and adaptability over the past year were a key to delivering this quarter's success. So a big thank you from myself, the Board and the management team. We really appreciate it. Thank you, everyone, for joining us today. We look forward to speaking to you again on our next earnings call in August. Have a great day. Thank you. Operator: This concludes today's call. Thank you for attending. You may now disconnect. Before you buy stock in Mativ, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Mativ wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $475,926!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,296,608!* Now, it’s worth noting Stock Advisor’s total average return is 981% — a market-crushing outperformance compared to 205% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors. See the 10 stocks » *Stock Advisor returns as of May 8, 2026. This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Mativ (MATV) Q1 2026 Earnings Call Transcript was originally published by The Motley Fool